Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: Volrustomig (Anti-CTLA4 & PD-1), Volrustomig, MEDI 5752
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $439 | 4-6 weeks | 4-6 weeks | |
| 5 mg | $1,230 | 4-6 weeks | 4-6 weeks | |
| 10 mg | $1,960 | 4-6 weeks | 4-6 weeks |
| Description | Volrustomig is a bi-engineered fragment crystallizable (Fc) domain, a monovalent bispecific IgG1 monoclonal antibody targeting the key immune checkpoint receptors PD-1 and CTLA-4. It boosts T-cell activation and antitumor immunity, making it a promising immunotherapy for various cancers. Molecular weight: 146.77 kDa. |
| Synonyms | Volrustomig (Anti-CTLA4 & PD-1), Volrustomig, MEDI 5752 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2407760-40-9 |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.